GALECTIN THERAPEUTICS INC (GALT:NASDAQ)
$3.68 -0.05 (-1.3405%)
Analysed GALECTIN THERAPEUTICS INC (GALT:NASDAQ) News Sources
GALT Stock Surges 22% — On Track For Best Day In Over A Year After FDA Clears Path For Late-Stage Belapectin Trial
23-06-2026
stocktwits.com
Galectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock?
03-04-2026
yahoo.com
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
31-03-2026
yahoo.com
Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology
11-05-2026
yahoo.com
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
27-05-2026
yahoo.com
Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
23-06-2026
yahoo.com
Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
04-08-2026
yahoo.com
Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update
14-08-2026
yahoo.com
Liver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight
24-08-2026
yahoo.com
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10-09-2026
yahoo.com
What is the current price of GALECTIN THERAPEUTICS INC (GALT:NASDAQ)?
The current price of GALECTIN THERAPEUTICS INC (GALT:NASDAQ) is $3.68.
GALECTIN THERAPEUTICS INC (GALT:NASDAQ) absolute price change since previous trading day?
The absolute price change of GALECTIN THERAPEUTICS INC (GALT:NASDAQ) since the previous trading day is $-0.05.
GALECTIN THERAPEUTICS INC (GALT:NASDAQ) percentage price change since previous trading day?
The percentage price change of GALECTIN THERAPEUTICS INC (GALT:NASDAQ) since the previous trading day is -1.3405%.
What is the most recent average sentiment score for GALECTIN THERAPEUTICS INC (GALT:NASDAQ)?
The most recent average sentiment score for GALECTIN THERAPEUTICS INC (GALT:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for GALECTIN THERAPEUTICS INC (GALT:NASDAQ)?
The most recent sentiment for GALECTIN THERAPEUTICS INC (GALT:NASDAQ) is .
SEC-8K** Filing Available For GALECTIN THERAPEUTICS INC (GALT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.